US2002142969A1PendingUtilityA1
Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
Priority: Aug 11, 1995Filed: Jul 30, 1996Published: Oct 3, 2002
Est. expiryAug 11, 2015(expired)· nominal 20-yr term from priority
A61P 33/02A61P 33/14C07D 213/61A61P 33/00C07D 277/06C07K 11/00A61P 33/10C07D 213/74C07C 275/62C07D 295/215C07C 271/22C07C 275/50
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the use of didepsipepides of the general formula (I) and their salts in which the radicals have the meaning given in the description, and to new didepsidpeptides and processes for their preparation.
Claims
exact text as granted — not AI-modified1 . Use of didepsipeptides of the general formula (I) and their salts
in which
R 1 represent hydrogen, straight-chain or branched alkyl, cycloalkyl, arylalkyl, aryl, heteroaryl, heteroarylalkyl, each of which is optionally substituted,
R 1 and R 2 together with the atoms to which they are bonded represent a 5- or 6-membered ring which can optionally be interrupted by oxygen, sulphur, sulphoxyl or sulphonyl and is optionally substituted,
R 2 and R 3 independently of one another represent hydrogen, straight-chain or branched alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, each of which is optionally substituted, or
R 2 and R 3 together represent a spirocyclic ring, which is optionally substituted,
R 4 and R 5 independently of one another represent hydrogen, straight-chain or branched alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, each of which is optionally substituted, or
R 4 and R 5 together represent a spirocyclic ring, which is optionally substituted,
A represents hydrogen, alkyl, aralkyl, formyl, alkoxydicarbonyl or a radical of the group G 1
in which
can denote carboxyl, thiocarboxyl, —CH═CH—NO 2 , —CH═CH—CN, —C═N—R 6 , sulphoxyl, sulphonyl, —P(O)—OR 7 or P(S)—OR 7 ,
R 6 represents hydrogen, hydroxyl, alkoxy, alkylcarbonyl, halogenoalkylcarbonyl, alkylsulphonyl, nitro or cyano, and
R 7 represents hydrogen or alkyl, and
Q represents straight-chain or branched alkyl, alkenyl, alkinyl, cycloalkyl, aryl, arylalkyl, hetaryl or hetarylalkyl, each of which is optionally substituted, or optionally represents a radical from the group G 2 and G 3
R 8 —Y—(G 2 )
in which
can denote carboxyl, thiocarboxyl or sulphonyl,
Y represents oxygen, sulphur or —NR 9 ,
R 8 in the case where Y represents nitrogen can denote a cyclic amino group linked via a nitrogen atom,
R 8 and R 9 independently of one another represent hydrogen, straight-chain or branched alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, hetaryl, hetarylalkyl, each of which is optionally substituted, or
R 8 and R 9 together with the adjacent N atom, [lacuna] a carbocyclic 5-, 6- or 7-membered ring system or a 7 to 10-membered bicyclic ring system which can optionally also be interrupted by oxygen, sulphur, sulphoxyl, sulphonyl, carbonyl, —N—O—, —N═, —NR 11 — or by quatemized nitrogen and is optionally substituted,
R 10 represents hydrogen or alkyl,
R 11 represent represents hydrogen, straight-chain or branched alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, alkoxycarbonyl, alkylcarbonyl, cycloalkylcarbonyl, cyano, aryl, arylalkyl, hetaryl, hetarylalkyl, each of which is optionally substituted, and
B represent represents hydroxyl, alkoxy, alkenyloxy, alkinyloxy, cycloalkyloxy, cycloalkylalkyloxy, aryloxy-, arylalkyloxy, hetaryloxy, hetarylalkyloxy, each of which is optionally substituted, or represents the radicals —NR 12 R 13 , —NR 14 —NR 12 R 13 and —NR 15 —OR 16 ,
in which
R 12 and R 13 independently of one another represent hydrogen, straight-chain or branched alkyl, alkylcarbonyl, alkyl sulphonyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, aryl, arylcarbonyl, arylsulphonyl, arylalkyl, hetaryl, hetarylcarbonyl, hetarylsulphonyl or hetarylalkyl, each of which is optionally substituted, or
R 12 and R 13 together with the adjacent N atom [lacuna] a carbocyclic 5-, 6-, 7- or 8-membered ring system or a 7 to 10-membered bicyclic ring system which can optionally also be interrupted by oxygen, sulphur, sulphoxyl, sulphonyl, carbonyl, —N—O, —N═, NR 11 — or by quaternized nitrogen and is optionally substituted,
R 14 represents hydrogen, straight-chain or branched alkyl, cycloalkyl, arylalkyl or hetarylalkyl, each of which is optionally substituted,
R 15 and R 16 independently of one another denote hydrogen, straight-chain or branched alkyl, alkylcarbonyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, arylalkyl or hetarylalkyl, each of which is optionally substituted,
R 15 and R 16 together with the adjacent N—O-group represent a carbocyclic 5-, 6- or 7-membered ring,
and their optical isomers and racemates,
for the control of endoparasites in medicine and veterinary medicine.
2 . New didepsipeptides of the general formula (Ia) and their salts
in which
R 1 represents hydrogen, straight-chain or branched C 1-4 -alkyl, C 3-6 -cycloalkyl, aryl-C 1-2 -alkyl or hetaryl-C 1-2 -alkyl, each of which is optionally substituted, and
R 1 and R 2 together with the atoms to which they are bonded represent a 5- or 6-membered ring which can optionally be interrupted by oxygen, sulphur, sulphoxyl or sulphonyl and is optionally substituted,
R 2 represents hydrogen, straight-chain or branched alkyl having up to 6 carbon atoms, alkenyl having up to 4 carbon atoms, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl-C 1-2 -alkyl, aryl, aryl-C 1-2 -alkyl, hetaryl, hetaryl-C 1-2 -alkyl each of which is optionally substituted,
R 3 and R 4 represent hydrogen,
R 5 represents hydrogen, straight-chain or branched alkyl having up to 6 carbon atoms, alkenyl having up to 4 carbon atoms, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl-C 1-2 -alkyl, aryl, aryl-C 1-2 -alkyl, hetaryl, hetaryl-C 1-2 -alkyl each of which is optionally substituted,
represents carboxyl, thiocarboxyl, —C═CH—NO 2 , —C═CH—CN, —C═N—R 6 , sulphoxyl, sulphonyl, —P(O)—OR 7 or P(S)—OR 7 ,
R 6 represents hydrogen, hydroxyl, C 1-4 -alkoxy, C 1-4 -alkylcarbonyl, C 1-4 -halogenoalkylcarbonyl, C 1-4 -alkylsulphonyl, nitro or cyano, and
R 7 represents hydrogen or C 1-4 -alkyl, and
Q represents straight-chain or branched C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkinyl, C 3-6 -cycloalkyl or hetaryl-C 1-2 -alkyl, each of which is optionally substituted, or optionally represents a radical from the group G 2 and G 3
R 8 —Y—(G 2 )
in which
can denote carboxyl, thiocarboxyl or sulphonyl,
Y represents oxygen, sulphur or —NR 9 ,
R 8 in the case where Y represents nitrogen can denote a cyclic amino group linked via a nitrogen atom,
R 8 and R 9 independently of one another represents hydrogen, straight-chain or branched C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkinyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl-C 1-2 -alkyl, hetaryl or hetaryl-C 1-2 -alkyl, each of which is optionally substituted, or
R 8 and R 9 together with the adjacent N atom represent a carbocyclic 5-, 6- or 7-membered ring system or a 7 to 10-membered bicyclic ring system which can optionally also be interrupted by oxygen, sulphur, sulphoxyl, sulphonyl, carbonyl, —N—O—, —N═, —NR 11 — or by quaternized nitrogen and is optionally substituted,
R 10 represents hydrogen or C 1-4 -alkyl, and
R 11 represents hydrogen, straight-chain or branched C 1-6 -alkyl, C 3-6 -cycloalkyl, C 2-6 -alkenyl, C 2-6 -alkinyl, C 3-6 -cycloalkyl, C 3-6 -Cycloalkyl-C 1-2 -alkyl, C 1-4 -alkoxycarbonyl, C 1-4 -alkylcarbonyl, C 3-6 -cycloalkylcarbonyl, cyano, aryl, aryl-C 1-2 -alkyl, hetaryl or hetaryl-C 1-2 -alkyl, each of which is optionally substituted, and
B represents C 1-6 -alkoxy, C 2-6 -alkenyloxy, C 2-6 -alkinyloxy, C 3-7 -cycloalkyloxy, C 3-7 -cycloalkyl-C 1-2 -alkyloxy, aryloxy-, aryl-C 1-2 -alkyloxy, hetaryloxy, hetaryl-C 1-2 -alkyloxy, each of which is optionally substituted, or
represents the amino radicals —NR 12 R 13 , —NR 14 —NR 12 R 13 and —NR 15 —OR 16 , in which
R 12 and R 13 independently of one another represent hydrogen, straight-chain or branched C 1-6 -alkyl, C 1-6 -alkylcarbonyl, C 1-6 -alkylsulphonyl, C 2-6 -alkenyl, C 2-6 -alkinyl, C 3-8 -cycloalkyl, C 3-8 -cycloalkyl-C 1-2 -alkyl, aryl, arylcarbonyl, arylsulphonyl, aryl-C 1-2 -alkyl, hetaryl, hetarylcarbonyl, hetarylsulphonyl or hetaryl-C 1-2 alkyl, each of which is optionally substituted, or
R 12 and R 13 together with the adjacent N atom represent a carbocyclic 5-, 6-, 7- or 8-membered ring system or a 7 to 10-membered bicyclic ring system, which can optionally also be interrupted by oxygen, sulphur, sulphoxyl, sulphonyl, carbonyl, —N—O, —N═, —NR 11 — or by quaternized nitrogen and is optionally substituted,
R 14 represents hydrogen, straight-chain or branched C 1-6 -alkyl, C 3-6 -cycloalkyl, each of which is optionally substituted,
R 15 and R 16 independently of one another denote hydrogen, straight-chain or branched C 1-6 -alkyl, C 1-6 -alkylcarbonyl, C 2-6 -alkenyl, C 2-6 -alkinyl or C 3-6 -cycloalkyl, each of which is optionally substituted, and
R 15 and R 16 together with the adjacent N—O-group represent a carbocyclic 5-, 6- or 7-membered ring,
with the proviso in the case where in formula (Ia) R 1 , R 5 and ═G═X together represent the following radicals:
R 1 represents hydrogen and methyl,
R 5 represents hydrogen,
represents carboxyl,
the radicals Q and B must fulfil the following condition:
Q represents radicals other than methyl,
B represents radicals other than —NH 2 ,
and with the proviso in the case where in formula (Ia) G 2 and ═G═X together represent the following radicals:
represents carboxyl,
G 2 represents tert-butyloxy, benzyloxy and 4-nitro-benzyloxy,
the radical B represents radicals other than tert-butyloxy, benzyloxy and 4-nitro-benzyloxy,
and their optical isomers and racemates.
3 . Process for the preparation of the new didepsipeptides of the general formula (Ia) and their salts according to claim 2
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 , G, Q, X and B have the meaning indicated in claim 2 ,
characterized in that
a) N-terminal-substituted amino acids of the general formula (II)
in which
the radicals R 1 , R 2 , R 3 , G, Q, and X have the meaning indicated in claim 2 , or their carboxyl-activated derivatives or their alkali metal salts, are reacted, if appropriate in the presence of a catalyst, if appropriate in the presence of an acid-binding agent and if appropriate in the presence of a diluent, with carboxylic acid derivatives of the general formula (III)
in which
the radicals R 4 , R 5 and B have the meaning indicated in claim 2 and Z represents a suitable leaving group for example halogen such as bromine, chlorine fluorine, or hydroxyl, or
b) N-terminal-deblocked didepsipeptides of the general formula (Ib)
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 and B have the meaning indicated in claim 2 , are reacted, if appropriate in the presence of a catalyst, if appropriate in the presence of an acid-binding agent and if appropriate in the presence of a diluent, with compounds of the general formula (IV)
in which
the radicals G, Q, W and X have the meaning indicated in claim 2 and W represents a suitable leaving group, for example halogen, alkoxy, alkylthio or aryloxy, or
c) N-terminal-deblocked didepsipeptides of the general formula (Ib)
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 and B have the meaning indicated in claim 2 , are reacted, if appropriate in the presence of a catalyst, if appropriate in the presence of an acid-binding agent and if appropriate in the presence of a diluent, with compounds of the general formulae (V) or (VI)
R 8 —N═C═X (V)
in which
the radicals R 8 , G 1 , X, X 1 and Y have the meaning indicated in claim 2 , or
for the preparation of the depsipeptides of the general formula (Ia) and their salts in which the group
represents carboxyl and Y represents oxygen,
d) N-terminal-deblocked didepsipeptides of the general formula (Ib)
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 and B have the meaning indicated in claim 2 ,
are reacted in a first reaction step with carbon dioxide and an alkali metal carbonate of the formula (VII)
M 2 CO 3 (VII)
in which
M represents a monovalent alkali metal cation, preferably lithium, sodium, potassium or caesium, in particular potassium or caesium,
then in a second reaction step the resulting alkali metal salt of the formula (VIII)
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 and B have the meaning indicated in claim 2 ,
M represents a metal cation equivalent bound like a salt,
is reacted with alkylating agents of the formula (IX)
R 8 —Hal (IX)
in which
R 8 has the meaning indicated in claim 2 and
Hal represents a halogen such as fluorine, chlorine, bromine or iodine,
if appropriate in the presence of a diluent and if appropriate in the presence of a basic reaction auxiliary, or
e) didepsipeptides of the general formula (Ic)
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 , G, W, X and B and have the meaning indicated in claim 2 and 3b, are reacted, if appropriate in the presence of a catalyst, if appropriate in the presence of an acid-binding agent and if appropriate in the presence of a diluent, with compounds of the general formula (X)
R 8 —Y—H (X)
in which
the radicals R 8 and Y have the meaning indicated above in claim 2 , or
f) didepsipeptides of the general formula (Id)
in which
the radicals R 1 , R 2 , R 3 , R 4 , R 5 , G, Q, X and B have the meaning indicated in claim 2 or their carboxyl-activated derivatives or their alkali metal salts are reacted, if appropriate in the presence of a catalyst, if appropriate in the presence of an acid-binding agent and if appropriate in the presence of a diluent, with compounds of the general formula (XI)
H—B (XI)
in which
the radical B has the meaning indicated above in claim 2 .
4 . Endoparasiticidal compositions, characterized in that they contain at least one didepsipeptide of the formula (I) according to claim 1 .
5 . Process for the production of endoparasiticidal compositions, characterized in that didepsipeptides of the formula (I) according to claim 1 are mixed with extenders and/or surface-active agents.
6 . Use of didepsipeptides of the formula (I) according to claim 1 for the production of endoparasiticidal compositions.Join the waitlist — get patent alerts
Track US2002142969A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.